We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSBC icon
476
HSBC
HSBC
$364B
$1.91M 0.03%
26,907
+26,188
+3,642% +$1.7M
GERN icon
477
Geron
GERN
$860M
$1.91M 0.03%
+1,392,980
New +$1.85M
TCBI icon
478
Texas Capital Bancshares
TCBI
$4.41B
$1.91M 0.03%
22,563
+22,503
+37,505% +$1.92M
NWG icon
479
NatWest
NWG
$76.1B
$1.89M 0.03%
133,649
+130,484
+4,123% +$1.84M
HXL icon
480
Hexcel
HXL
$7.88B
$1.87M 0.03%
29,902
+27,828
+1,342% +$1.71M
ETR icon
481
Entergy
ETR
$50.8B
$1.87M 0.03%
20,072
+15,311
+322% +$1.35M
BAX icon
482
Baxter International
BAX
$14.7B
$1.87M 0.03%
82,069
+80,755
+6,146% +$2.05M
BCS icon
483
Barclays
BCS
$94.5B
$1.86M 0.03%
90,146
+77,987
+641% +$1.54M
DECK icon
484
Deckers Outdoor
DECK
$13.6B
$1.86M 0.03%
18,361
+16,505
+889% +$1.8M
APLS
485
DELISTED
Apellis Pharmaceuticals
APLS
$1.86M 0.03%
+82,067
New +$1.91M
LFUS icon
486
Littelfuse
LFUS
$11.8B
$1.85M 0.03%
7,157
+6,842
+2,172% +$1.71M
ZION icon
487
Zions Bancorporation
ZION
$10.5B
$1.85M 0.03%
32,740
+29,678
+969% +$1.65M
HPQ icon
488
HP
HPQ
$26.4B
$1.83M 0.03%
67,283
+61,713
+1,108% +$1.64M
WWD icon
489
Woodward
WWD
$22.1B
$1.83M 0.03%
7,240
+7,174
+10,870% +$1.78M
PHM icon
490
Pultegroup
PHM
$25.1B
$1.82M 0.03%
13,771
+12,542
+1,021% +$1.56M
MUFG icon
491
Mitsubishi UFJ Financial
MUFG
$246B
$1.82M 0.03%
113,915
+106,078
+1,354% +$1.57M
LYG icon
492
Lloyds Banking Group
LYG
$90.3B
$1.81M 0.03%
399,709
+362,016
+960% +$1.58M
MET icon
493
MetLife
MET
$61.9B
$1.81M 0.03%
22,002
+18,952
+621% +$1.49M
MAN icon
494
ManpowerGroup
MAN
$2.55B
$1.81M 0.03%
47,781
+47,150
+7,472% +$1.94M
SONY icon
495
Sony
SONY
$131B
$1.81M 0.03%
62,768
+53,385
+569% +$1.44M
WTW icon
496
Willis Towers Watson
WTW
$31.5B
$1.8M 0.03%
5,215
+4,926
+1,704% +$1.6M
CI icon
497
Cigna
CI
$72.4B
$1.79M 0.03%
6,222
+5,738
+1,186% +$1.7M
AL
498
DELISTED
Air Lease Corp
AL
$1.78M 0.03%
27,944
+25,770
+1,185% +$1.54M
APD icon
499
Air Products & Chemicals
APD
$65.6B
$1.76M 0.03%
6,437
+5,938
+1,190% +$1.72M
NXST icon
500
Nexstar Media Group
NXST
$5.99B
$1.74M 0.03%
8,796
+8,027
+1,044% +$1.57M

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.